top of page
Search

Ayala Pharmaceuticals Announces $25 Million Strategic Financing

  • Writer: SBIJI Innovation
    SBIJI Innovation
  • Feb 21, 2021
  • 1 min read

Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023

Funds Expected to Support the Recently Announced Accelerated Development of AL102 for the Treatment of Desmoid Tumors into Pivotal Phase 2/3 Study


 
 
 

Recent Posts

See All

コメント


A Member firm of SBI Group, Japan

© 2020 SBI JI Innovation Advisory Ltd. All rights reserved

bottom of page